Literature DB >> 9715418

Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.

J C Luo1, S J Hwang, C R Lai, C L Lu, C P Li, S H Tsay, J C Wu, F Y Chang, S D Lee.   

Abstract

In patients with chronic hepatitis C, the relationships between serum alanine aminotransferase (ALT) levels, histological liver injury and serum hepatitis C virus (HCV) RNA titres remain controversial. To evaluate these relationships, 93 Chinese patients with histological diagnosis of chronic hepatitis C were enrolled for this study. Serum ALT levels, HCV-RNA titres and HCV genotypes were examined. The histology was evaluated according to a modified histological activity score based on the degree of periportal necro-inflammation, intralobular necro-inflammation, portal inflammation, total necro-inflammation and fibrosis. The mean serum ALT level was significantly higher in patients with severe intralobular necro-inflammation activity than in patients with mild or no activity (P = 0.013). However, scores of intralobular activity were only weakly correlated with serum ALT levels (r = 0.27) and could not be used to adequately predict ALT values. Serum ALT levels showed no significant correlation with the scores of portal inflammation, periportal necro-inflammation, total necro-inflammation and fibrosis. Also, there was no significant difference in the mean serum ALT level among different serum HCV-RNA levels and HCV genotypes. Serum HCV-RNA titres and genotypes showed no significant correlation with liver histology and serum HCV-RNA titres were only weakly correlated with the total necro-inflammatory score (r = 0.27). In conclusion, although serum ALT levels were higher in patients with more severe intralobular necro-inflammatory activity, the correlation was not strong enough to adequately predict ALT values. Serum HCV-RNA titres and genotypes also showed no significant correlation with serum ALT levels and liver histologies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715418     DOI: 10.1111/j.1440-1746.1998.tb00714.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Yu Yang; Arthur J McCullough; Susan Marczewski; Carole Bennett; Satish C Kalhan
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 2.566

2.  Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice.

Authors:  Norio Horiguchi; Fouad Lafdil; Andrew M Miller; Ogyi Park; Hua Wang; Mohanraj Rajesh; Partha Mukhopadhyay; Xin Yuan Fu; Pal Pacher; Bin Gao
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

3.  Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.

Authors:  H Eguchi; K Umeshita; M Sakon; H Nagano; Y Ito; S I Kishimoto; K Dono; S Nakamori; T Takeda; M Gotoh; K Wakasa; N Matsuura; M Monden
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

4.  Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection.

Authors:  Hassan R Mohamed; Mohamed Yaqoot Abdel-Azziz; Kkaled Refaat Zalata; Ahmed M M Abdel-Razik
Journal:  Int J Health Sci (Qassim)       Date:  2009-07

5.  Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.

Authors:  Hoang Van Tong; Le Huu Song; Nghiem Xuan Hoan; Bui Khac Cuong; Bui Tien Sy; Ho Anh Son; Do Quyet; Vu Quoc Binh; Peter G Kremsner; Claus Thomas Bock; Thirumalaisamy P Velavan; Nguyen Linh Toan
Journal:  BMC Infect Dis       Date:  2015-01-23       Impact factor: 3.090

6.  Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.

Authors:  Ngo Tat Trung; Dang Chieu Duong; Hoang Van Tong; Tran Thi Thu Hien; Phan Quoc Hoan; Mai Hong Bang; Mai Thanh Binh; Thai Doan Ky; Nguyen Lam Tung; Nguyen Tien Thinh; Vu Viet Sang; Le Thi Phuong Thao; C-Thomas Bock; Thirumalaisamy P Velavan; Christian G Meyer; Le Huu Song; Nguyen Linh Toan
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

7.  Factors associated or related to with pathological severity of nonalcoholic fatty liver disease.

Authors:  Kyung Sik Park; Yeong Seok Lee; Heo Won Park; Sang Hyuck Seo; Byung Guk Jang; Jun Young Hwang; Kwang Bum Cho; Jae Seok Hwang; Sung Hoon Ahn; Yu Na Kang; Gap Chul Kim
Journal:  Korean J Intern Med       Date:  2004-03       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.